Clinical Trials identified as a priority, with a $33 million boost from the MRFF

Today, on Clinical Trials Day, the South Australian Health and Medical Research Institute (SAHMRI) is thrilled by the Medical Research Future Fund’s (MRFF) announcement to invest $33 million in clinical trial capacity.

This investment will include $18 million in funding for new clinical trials and $8 million into clinical research fellowships to help ensure that Australia can attract and retain the best and brightest minds in research. The Federal Government is also committing $7 million over four years to help redesign clinical trial operating systems.

SAHMRI’s Deputy Director and Heart Health Theme Leader, Professor Steve Nicholls, said that this announcement has come at a vital time.

“This funding is a major step forward in our ability to conduct high-quality clinical trials,” Professor Nicholls said.

“This is wonderful news for SAHMRI, because it gives us the opportunity to continue to build a world-leading clinical trial platform in South Australia.

“Clinical trials are an important part of helping us achieve our vision of translating research into improved health outcomes for our community.”